Dozens of clinics have gathered across the United States to tackle the astonishing and troubling aspects of COVID-19: effects that persist for some weeks and months after the infection subsided (19). Jan)
A large study conducted during the epidemic estimated that 1 in 3 COVID-19 survivors were diagnosed with neurological or psychiatric symptoms within six months of infection.
The study, published Tuesday in the peer-reviewed journal The Lancet Psychiatry, used electronic health records of more than 230,000 COVID-19 patients, mostly in the United States, looking at 14 different brain and mental health disorders.
Thirty-four percent of the survivors were diagnosed with at least one of these symptoms, with 13% of those being the first recorded neurological or psychiatric diagnosis. Mental health diagnoses were most common in patients, with 17% diagnosed with anxiety disorder and 14% diagnosed with mood disorder.
Although the neurological diagnosis is uncommon. But it was more common in seriously ill patients during COVID-19 infection. For example, 7% of patients in intensive care had cerebrovascular disease and 2% were diagnosed with dementia.
“It shows the toll that COVID receives, not just against (the disease itself) but also the consequences of the condition, which can be very complex, not only to the extent of the disease itself. But only related to the brain But also other organs in the body, ”said Dr. William Li, president and medical director of the Angiogenesis Foundation, a nonprofit dedicated to the study of abnormal blood vessel growth.
Children and COVID: Why do children fare better than adults against COVID-19? Their innate immune response might have stopped the virus earlier.
The study authors also studied approximately 100,000 influenza patients and more than 230,000 patients diagnosed with respiratory infections during the same period and found that neurological and psychiatric diagnoses were more common in COVID-treated patients. 19
The results showed that there was a 44% greater risk for a diagnosis of brain or mental health after COVID-19 than influenza and 16% more at risk than respiratory infection, according to the study.
Julie Walsh-Messinger An assistant professor in the Department of Psychology at the University of Dayton said coronavirus infection is possible. But these psychiatric diseases can be caused by the stress of the epidemic itself.
“We saw higher rates of depression and anxiety across the board, regardless of (COVID-19 infection) or not,” she said. How common is stress, because of a lack of sociability, a lack of the ability to participate in activities that people normally enjoy, how much they fear the future and how specific it is. The progression of the disease “
However, the study is an important first step in what doctors can expect from COVID-19 patients, she added.
When seasonal allergies return, patients may worry that their symptoms may be COVID-19, but there are some key differences.
The scale of the study also shows how the long-term effects of COVID-19 can affect a nation’s healthcare system, even if the disease is gone, says lead author Paul Harrison, a professor at the University of Oxford. In the UK
“Although the personal risk for most anomalies is small. But the impact of the entire population may be important to the healthcare system and society because of the size of the epidemic, ”he said.“ Health care systems need to be resourced to address the projected needs. ”
And with the Centers for Disease Control and Prevention reporting 60,000 new cases of COVID-19 per day, the need for healthcare services after COVID-19 infection may be exacerbated by physical therapist Noah Greenspan. Heart and lungs and founder of the Pulmonary Wellness Foundation in New York City.
“Even though at this time we shut the valve and no one was infected with COVID, there was still a whole group of people affected,” he said. There’s no new damage, but we have to deal with the progression of this syndrome that people are experiencing for years to come. ”
Follow Adrianna Rodriguez on Twitter: @AdriannaUSAT.
Patient health and safety coverage at USA TODAY is made possible in part by funding from the Masimo Foundation for Ethics, Innovation and Competition in Healthcare.The Masimo Foundation does not provide editorial information.
Read or share this story: https://www.usatoday.com/story/news/health/2021/04/08/covid-1-3-survivors-diagnosed-brain-mental-health-disorder/7121104002/